Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
BadThe stock is in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
—
—
—
Genomic Valley Biotech Ltd is conducting research in the field of Biotechnology (Plant & Animal) and also to undertake commercial production of Plant Tissue Cultured Plants of different species to feed the genetically improved plant market
Customise key metrics, see detailed forecasts, download stock data and more
Pledged promoter holdings is insignificant
In last 3 months, mutual fund holding of the company has almost stayed constant
Genomic Valley Biotech Ltd - 539206 - Please Find Enclosed Herewith Un Audited Standalone Financial Results For The Quarter And Half Yearly Ended On September 30Th ,2024 | Download
Genomic Valley Biotech Ltd - 539206 - Please Find Enclosed Herewith Un Audited Standalone Financial Results For The Quarter And Half Yearly Ended On September 30Th ,2024 | Download
Genomic Valley Biotech Ltd - 539206 - Board Meeting Outcome for Please Find Enclosed Herewith Outcome Of Board Meeting Pusuant To Regulation 30 Of Sebi ( LODR)Regulation ,2015 Held On Today I.E. 07Th October 2024 | Download
Genomic Valley Biotech Ltd - 539206 - Board Meeting Outcome for Please Find Enclosed Herewith Outcome Of Board Meeting Pusuant To Regulation 30 Of Sebi ( LODR)Regulation ,2015 Held On Today I.E. 07Th October 2024 | Download
Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant